Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells
Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells Jichun Yang , Claudia E. Robert , Brant R. Burkhardt , Robert A. Young , Jianmei Wu , Zhiyong Gao and Bryan A. Wolf From the Department of Pathology and Laboratory Medicine, The Children’s Ho...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2005-11, Vol.54 (11), p.3217-3228 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3228 |
---|---|
container_issue | 11 |
container_start_page | 3217 |
container_title | Diabetes (New York, N.Y.) |
container_volume | 54 |
creator | JICHUN YANG ROBERT, Claudia E BURKHARDT, Brant R YOUNG, Robert A JIANMEI WU ZHIYONG GAO WOLF, Bryan A |
description | Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells
Jichun Yang ,
Claudia E. Robert ,
Brant R. Burkhardt ,
Robert A. Young ,
Jianmei Wu ,
Zhiyong Gao and
Bryan A. Wolf
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia and University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania
Address correspondence and reprint requests to Dr. Bryan A. Wolf, Department of Pathology and Laboratory Medicine, Children’s
Hospital of Philadelphia, 5135 Main Bldg, 34th St. and Civic Center Blvd., Philadelphia, PA 19104-4399. E-mail: wolfb{at}mail.med.upenn.edu
Abstract
Pancreatic-derived factor (PANDER) is an islet-specific cytokine present in both pancreatic α- and β-cells, which, in vitro,
induces β-cell apoptosis of primary islet and cell lines. In this study, we investigated whether PANDER is secreted by pancreatic
α- and β-cells and whether PANDER secretion is regulated by glucose and other insulin secretagogues. In mouse-derived insulin-secreting
β-TC3 cells, PANDER secretion in the presence of stimulatory concentrations of glucose was 2.8 ± 0.4-fold higher ( P < 0.05) than without glucose. Insulin secretion was similarly increased by glucose in the same cells. The total concentration
of secreted PANDER in the medium was ∼6–10 ng/ml (0.3–0.5 nmol/l) after a 24-h culture with glucose. l -Glucose failed to stimulate PANDER secretion in β-TC3 cells. KCl stimulated PANDER secretion 2.1 ± 0.1-fold compared with
control without glucose. An l -type Ca 2+ channel inhibitor, nifedipine, completely blocked both glucose- or KCl-induced insulin and PANDER secretion. In rat-derived
INS-1 cells, glucose (20 mmol/l) stimulated PANDER secretion 4.4 ± 0.9-fold, while leucine plus glutamine stimulated 4.4 ±
0.7-fold compared with control without glucose. In mouse islets overexpressing PANDER, glucose (20 mmol/l) stimulated PANDER
secretion 3.2 ± 0.5-fold ( P < 0.05) compared with basal (3 mmol/l glucose). PANDER was also secreted by α-TC3 cells but was not stimulated by glucose.
Mutations of cysteine 229 or of cysteines 91 and 229 to serine, which may form one disulfide bond, and truncation of the COOH-terminus
or NH 2 -terminus of PANDER all resulted in failure of PANDER secretion, even though these mutant or truncated PANDERs were highly
expressed within the cells. In conclusion, we found that 1 ) PANDER is secreted from both pancreatic α- and β-cells, 2 ) glucose sti |
doi_str_mv | 10.2337/diabetes.54.11.3217 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_17387352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A138487747</galeid><sourcerecordid>A138487747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-d29638809a5280f45428049e91984267ea186e738dca19074abab2e7000984ee3</originalsourceid><addsrcrecordid>eNqFkttuEzEQhi0EoqHwBEhob0BUwotPu7YvQ9qESilUHCTuLMc7mxjtodi7HF6LB-GZcEhQqBQJzcXYnu-f8WgGoceU5Ixz-bLydgUDxLwQOaU5Z1TeQROqucacyU930YQQyjCVWp6gBzF-JoSUye6jE1oyoYVQE9RegdvYzsc2Zn2dLZrR9RHwZVeNDqrsPbgAg--7bfDadulmB-_wOQT_NcXn1g19yJ5fT9-cX7zL0nE-veKvzjLf_YNnv37iGTRNfIju1baJ8GjvT9HH-cWH2Wu8fLu4nE2X2BWFHHDFdMmVItoWTJFaFCI5oUFTrQQrJViqSpBcVc5STaSwK7tiIFODCQDgp-jZLu9N6L-MEAfT-ujSD2wH_RhNqWTKqMh_QZqKSF6wBOIduLYNGN_V_RCsW0MHwTZ9B7VPz1PKlVBSCpn4_AifrILWu6OCs1uCxAzwfVjbMUajFsvbLN-xLvQxBqjNTfCtDT8MJWa7G-bvbphCGErNdjeS6sm-13HVQnXQ7JchAU_3gI3ONnVIA_TxwEmWxvGHe7HjNn69-eYDHModq_sbj47Peg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17387352</pqid></control><display><type>article</type><title>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>JICHUN YANG ; ROBERT, Claudia E ; BURKHARDT, Brant R ; YOUNG, Robert A ; JIANMEI WU ; ZHIYONG GAO ; WOLF, Bryan A</creator><creatorcontrib>JICHUN YANG ; ROBERT, Claudia E ; BURKHARDT, Brant R ; YOUNG, Robert A ; JIANMEI WU ; ZHIYONG GAO ; WOLF, Bryan A</creatorcontrib><description>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells
Jichun Yang ,
Claudia E. Robert ,
Brant R. Burkhardt ,
Robert A. Young ,
Jianmei Wu ,
Zhiyong Gao and
Bryan A. Wolf
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia and University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania
Address correspondence and reprint requests to Dr. Bryan A. Wolf, Department of Pathology and Laboratory Medicine, Children’s
Hospital of Philadelphia, 5135 Main Bldg, 34th St. and Civic Center Blvd., Philadelphia, PA 19104-4399. E-mail: wolfb{at}mail.med.upenn.edu
Abstract
Pancreatic-derived factor (PANDER) is an islet-specific cytokine present in both pancreatic α- and β-cells, which, in vitro,
induces β-cell apoptosis of primary islet and cell lines. In this study, we investigated whether PANDER is secreted by pancreatic
α- and β-cells and whether PANDER secretion is regulated by glucose and other insulin secretagogues. In mouse-derived insulin-secreting
β-TC3 cells, PANDER secretion in the presence of stimulatory concentrations of glucose was 2.8 ± 0.4-fold higher ( P < 0.05) than without glucose. Insulin secretion was similarly increased by glucose in the same cells. The total concentration
of secreted PANDER in the medium was ∼6–10 ng/ml (0.3–0.5 nmol/l) after a 24-h culture with glucose. l -Glucose failed to stimulate PANDER secretion in β-TC3 cells. KCl stimulated PANDER secretion 2.1 ± 0.1-fold compared with
control without glucose. An l -type Ca 2+ channel inhibitor, nifedipine, completely blocked both glucose- or KCl-induced insulin and PANDER secretion. In rat-derived
INS-1 cells, glucose (20 mmol/l) stimulated PANDER secretion 4.4 ± 0.9-fold, while leucine plus glutamine stimulated 4.4 ±
0.7-fold compared with control without glucose. In mouse islets overexpressing PANDER, glucose (20 mmol/l) stimulated PANDER
secretion 3.2 ± 0.5-fold ( P < 0.05) compared with basal (3 mmol/l glucose). PANDER was also secreted by α-TC3 cells but was not stimulated by glucose.
Mutations of cysteine 229 or of cysteines 91 and 229 to serine, which may form one disulfide bond, and truncation of the COOH-terminus
or NH 2 -terminus of PANDER all resulted in failure of PANDER secretion, even though these mutant or truncated PANDERs were highly
expressed within the cells. In conclusion, we found that 1 ) PANDER is secreted from both pancreatic α- and β-cells, 2 ) glucose stimulates PANDER secretion dose dependently in β-cell lines and primary islets but not in α-cells, 3 ) PANDER is likely cosecreted with insulin via the same regulatory mechanisms, and 4 ) structure and conformation is vital for PANDER secretion.
CCH, carbachol
FBS, fetal bovine serum
IFN, interferon
IL, interleukin
KRBB, Krebs-Ringer bicarbonate buffer
PANDER, pancreatic-derived factor (or FAM3B)
TBST, Tris-buffered saline with Tween
TNF, tumor necrosis factor
Footnotes
Accepted August 3, 2005.
Received May 6, 2005.
DIABETES</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.54.11.3217</identifier><identifier>PMID: 16249448</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Amino Acid Sequence ; Animals ; Biological and medical sciences ; Cell Line ; Cytokines - chemistry ; Cytokines - genetics ; Cytokines - metabolism ; Diabetes. Impaired glucose tolerance ; Dose-Response Relationship, Drug ; Drug therapy ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Genetic aspects ; Glucose - antagonists & inhibitors ; Glucose - pharmacology ; Glutamine - pharmacology ; Health aspects ; Insulin-Secreting Cells - drug effects ; Insulin-Secreting Cells - metabolism ; Interferon ; Leucine - pharmacology ; Medical sciences ; Mice ; Mutation ; Nifedipine - pharmacology ; Pancreatic beta cells ; Potassium Chloride - antagonists & inhibitors ; Potassium Chloride - pharmacology ; Time Factors ; Type 1 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2005-11, Vol.54 (11), p.3217-3228</ispartof><rights>2006 INIST-CNRS</rights><rights>COPYRIGHT 2005 American Diabetes Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-d29638809a5280f45428049e91984267ea186e738dca19074abab2e7000984ee3</citedby><cites>FETCH-LOGICAL-c557t-d29638809a5280f45428049e91984267ea186e738dca19074abab2e7000984ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17252848$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16249448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JICHUN YANG</creatorcontrib><creatorcontrib>ROBERT, Claudia E</creatorcontrib><creatorcontrib>BURKHARDT, Brant R</creatorcontrib><creatorcontrib>YOUNG, Robert A</creatorcontrib><creatorcontrib>JIANMEI WU</creatorcontrib><creatorcontrib>ZHIYONG GAO</creatorcontrib><creatorcontrib>WOLF, Bryan A</creatorcontrib><title>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells
Jichun Yang ,
Claudia E. Robert ,
Brant R. Burkhardt ,
Robert A. Young ,
Jianmei Wu ,
Zhiyong Gao and
Bryan A. Wolf
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia and University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania
Address correspondence and reprint requests to Dr. Bryan A. Wolf, Department of Pathology and Laboratory Medicine, Children’s
Hospital of Philadelphia, 5135 Main Bldg, 34th St. and Civic Center Blvd., Philadelphia, PA 19104-4399. E-mail: wolfb{at}mail.med.upenn.edu
Abstract
Pancreatic-derived factor (PANDER) is an islet-specific cytokine present in both pancreatic α- and β-cells, which, in vitro,
induces β-cell apoptosis of primary islet and cell lines. In this study, we investigated whether PANDER is secreted by pancreatic
α- and β-cells and whether PANDER secretion is regulated by glucose and other insulin secretagogues. In mouse-derived insulin-secreting
β-TC3 cells, PANDER secretion in the presence of stimulatory concentrations of glucose was 2.8 ± 0.4-fold higher ( P < 0.05) than without glucose. Insulin secretion was similarly increased by glucose in the same cells. The total concentration
of secreted PANDER in the medium was ∼6–10 ng/ml (0.3–0.5 nmol/l) after a 24-h culture with glucose. l -Glucose failed to stimulate PANDER secretion in β-TC3 cells. KCl stimulated PANDER secretion 2.1 ± 0.1-fold compared with
control without glucose. An l -type Ca 2+ channel inhibitor, nifedipine, completely blocked both glucose- or KCl-induced insulin and PANDER secretion. In rat-derived
INS-1 cells, glucose (20 mmol/l) stimulated PANDER secretion 4.4 ± 0.9-fold, while leucine plus glutamine stimulated 4.4 ±
0.7-fold compared with control without glucose. In mouse islets overexpressing PANDER, glucose (20 mmol/l) stimulated PANDER
secretion 3.2 ± 0.5-fold ( P < 0.05) compared with basal (3 mmol/l glucose). PANDER was also secreted by α-TC3 cells but was not stimulated by glucose.
Mutations of cysteine 229 or of cysteines 91 and 229 to serine, which may form one disulfide bond, and truncation of the COOH-terminus
or NH 2 -terminus of PANDER all resulted in failure of PANDER secretion, even though these mutant or truncated PANDERs were highly
expressed within the cells. In conclusion, we found that 1 ) PANDER is secreted from both pancreatic α- and β-cells, 2 ) glucose stimulates PANDER secretion dose dependently in β-cell lines and primary islets but not in α-cells, 3 ) PANDER is likely cosecreted with insulin via the same regulatory mechanisms, and 4 ) structure and conformation is vital for PANDER secretion.
CCH, carbachol
FBS, fetal bovine serum
IFN, interferon
IL, interleukin
KRBB, Krebs-Ringer bicarbonate buffer
PANDER, pancreatic-derived factor (or FAM3B)
TBST, Tris-buffered saline with Tween
TNF, tumor necrosis factor
Footnotes
Accepted August 3, 2005.
Received May 6, 2005.
DIABETES</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cytokines - chemistry</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug therapy</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Genetic aspects</subject><subject>Glucose - antagonists & inhibitors</subject><subject>Glucose - pharmacology</subject><subject>Glutamine - pharmacology</subject><subject>Health aspects</subject><subject>Insulin-Secreting Cells - drug effects</subject><subject>Insulin-Secreting Cells - metabolism</subject><subject>Interferon</subject><subject>Leucine - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mutation</subject><subject>Nifedipine - pharmacology</subject><subject>Pancreatic beta cells</subject><subject>Potassium Chloride - antagonists & inhibitors</subject><subject>Potassium Chloride - pharmacology</subject><subject>Time Factors</subject><subject>Type 1 diabetes</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkttuEzEQhi0EoqHwBEhob0BUwotPu7YvQ9qESilUHCTuLMc7mxjtodi7HF6LB-GZcEhQqBQJzcXYnu-f8WgGoceU5Ixz-bLydgUDxLwQOaU5Z1TeQROqucacyU930YQQyjCVWp6gBzF-JoSUye6jE1oyoYVQE9RegdvYzsc2Zn2dLZrR9RHwZVeNDqrsPbgAg--7bfDadulmB-_wOQT_NcXn1g19yJ5fT9-cX7zL0nE-veKvzjLf_YNnv37iGTRNfIju1baJ8GjvT9HH-cWH2Wu8fLu4nE2X2BWFHHDFdMmVItoWTJFaFCI5oUFTrQQrJViqSpBcVc5STaSwK7tiIFODCQDgp-jZLu9N6L-MEAfT-ujSD2wH_RhNqWTKqMh_QZqKSF6wBOIduLYNGN_V_RCsW0MHwTZ9B7VPz1PKlVBSCpn4_AifrILWu6OCs1uCxAzwfVjbMUajFsvbLN-xLvQxBqjNTfCtDT8MJWa7G-bvbphCGErNdjeS6sm-13HVQnXQ7JchAU_3gI3ONnVIA_TxwEmWxvGHe7HjNn69-eYDHModq_sbj47Peg</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>JICHUN YANG</creator><creator>ROBERT, Claudia E</creator><creator>BURKHARDT, Brant R</creator><creator>YOUNG, Robert A</creator><creator>JIANMEI WU</creator><creator>ZHIYONG GAO</creator><creator>WOLF, Bryan A</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20051101</creationdate><title>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells</title><author>JICHUN YANG ; ROBERT, Claudia E ; BURKHARDT, Brant R ; YOUNG, Robert A ; JIANMEI WU ; ZHIYONG GAO ; WOLF, Bryan A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-d29638809a5280f45428049e91984267ea186e738dca19074abab2e7000984ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cytokines - chemistry</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug therapy</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Genetic aspects</topic><topic>Glucose - antagonists & inhibitors</topic><topic>Glucose - pharmacology</topic><topic>Glutamine - pharmacology</topic><topic>Health aspects</topic><topic>Insulin-Secreting Cells - drug effects</topic><topic>Insulin-Secreting Cells - metabolism</topic><topic>Interferon</topic><topic>Leucine - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mutation</topic><topic>Nifedipine - pharmacology</topic><topic>Pancreatic beta cells</topic><topic>Potassium Chloride - antagonists & inhibitors</topic><topic>Potassium Chloride - pharmacology</topic><topic>Time Factors</topic><topic>Type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JICHUN YANG</creatorcontrib><creatorcontrib>ROBERT, Claudia E</creatorcontrib><creatorcontrib>BURKHARDT, Brant R</creatorcontrib><creatorcontrib>YOUNG, Robert A</creatorcontrib><creatorcontrib>JIANMEI WU</creatorcontrib><creatorcontrib>ZHIYONG GAO</creatorcontrib><creatorcontrib>WOLF, Bryan A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JICHUN YANG</au><au>ROBERT, Claudia E</au><au>BURKHARDT, Brant R</au><au>YOUNG, Robert A</au><au>JIANMEI WU</au><au>ZHIYONG GAO</au><au>WOLF, Bryan A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>54</volume><issue>11</issue><spage>3217</spage><epage>3228</epage><pages>3217-3228</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells
Jichun Yang ,
Claudia E. Robert ,
Brant R. Burkhardt ,
Robert A. Young ,
Jianmei Wu ,
Zhiyong Gao and
Bryan A. Wolf
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia and University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania
Address correspondence and reprint requests to Dr. Bryan A. Wolf, Department of Pathology and Laboratory Medicine, Children’s
Hospital of Philadelphia, 5135 Main Bldg, 34th St. and Civic Center Blvd., Philadelphia, PA 19104-4399. E-mail: wolfb{at}mail.med.upenn.edu
Abstract
Pancreatic-derived factor (PANDER) is an islet-specific cytokine present in both pancreatic α- and β-cells, which, in vitro,
induces β-cell apoptosis of primary islet and cell lines. In this study, we investigated whether PANDER is secreted by pancreatic
α- and β-cells and whether PANDER secretion is regulated by glucose and other insulin secretagogues. In mouse-derived insulin-secreting
β-TC3 cells, PANDER secretion in the presence of stimulatory concentrations of glucose was 2.8 ± 0.4-fold higher ( P < 0.05) than without glucose. Insulin secretion was similarly increased by glucose in the same cells. The total concentration
of secreted PANDER in the medium was ∼6–10 ng/ml (0.3–0.5 nmol/l) after a 24-h culture with glucose. l -Glucose failed to stimulate PANDER secretion in β-TC3 cells. KCl stimulated PANDER secretion 2.1 ± 0.1-fold compared with
control without glucose. An l -type Ca 2+ channel inhibitor, nifedipine, completely blocked both glucose- or KCl-induced insulin and PANDER secretion. In rat-derived
INS-1 cells, glucose (20 mmol/l) stimulated PANDER secretion 4.4 ± 0.9-fold, while leucine plus glutamine stimulated 4.4 ±
0.7-fold compared with control without glucose. In mouse islets overexpressing PANDER, glucose (20 mmol/l) stimulated PANDER
secretion 3.2 ± 0.5-fold ( P < 0.05) compared with basal (3 mmol/l glucose). PANDER was also secreted by α-TC3 cells but was not stimulated by glucose.
Mutations of cysteine 229 or of cysteines 91 and 229 to serine, which may form one disulfide bond, and truncation of the COOH-terminus
or NH 2 -terminus of PANDER all resulted in failure of PANDER secretion, even though these mutant or truncated PANDERs were highly
expressed within the cells. In conclusion, we found that 1 ) PANDER is secreted from both pancreatic α- and β-cells, 2 ) glucose stimulates PANDER secretion dose dependently in β-cell lines and primary islets but not in α-cells, 3 ) PANDER is likely cosecreted with insulin via the same regulatory mechanisms, and 4 ) structure and conformation is vital for PANDER secretion.
CCH, carbachol
FBS, fetal bovine serum
IFN, interferon
IL, interleukin
KRBB, Krebs-Ringer bicarbonate buffer
PANDER, pancreatic-derived factor (or FAM3B)
TBST, Tris-buffered saline with Tween
TNF, tumor necrosis factor
Footnotes
Accepted August 3, 2005.
Received May 6, 2005.
DIABETES</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>16249448</pmid><doi>10.2337/diabetes.54.11.3217</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-1797 |
ispartof | Diabetes (New York, N.Y.), 2005-11, Vol.54 (11), p.3217-3228 |
issn | 0012-1797 1939-327X |
language | eng |
recordid | cdi_proquest_miscellaneous_17387352 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Amino Acid Sequence Animals Biological and medical sciences Cell Line Cytokines - chemistry Cytokines - genetics Cytokines - metabolism Diabetes. Impaired glucose tolerance Dose-Response Relationship, Drug Drug therapy Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Genetic aspects Glucose - antagonists & inhibitors Glucose - pharmacology Glutamine - pharmacology Health aspects Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - metabolism Interferon Leucine - pharmacology Medical sciences Mice Mutation Nifedipine - pharmacology Pancreatic beta cells Potassium Chloride - antagonists & inhibitors Potassium Chloride - pharmacology Time Factors Type 1 diabetes |
title | Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic β-Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A52%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanisms%20of%20Glucose-Induced%20Secretion%20of%20Pancreatic-Derived%20Factor%20(PANDER%20or%20FAM3B)%20in%20Pancreatic%20%CE%B2-Cells&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=JICHUN%20YANG&rft.date=2005-11-01&rft.volume=54&rft.issue=11&rft.spage=3217&rft.epage=3228&rft.pages=3217-3228&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.54.11.3217&rft_dat=%3Cgale_proqu%3EA138487747%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17387352&rft_id=info:pmid/16249448&rft_galeid=A138487747&rfr_iscdi=true |